Growth Metrics

Soleno Therapeutics (SLNO) Gross Profit (2015 - 2026)

Soleno Therapeutics (SLNO) reported Gross Profit of $93.4 million for Q1 2026, up 2.79% on a QoQ basis from $90.9 million in Q4 2025.

Soleno Therapeutics (SLNO) has 5 years of Gross Profit data on file, last reported at $93.4 million in Q1 2026.

  • Quarterly Gross Profit changed N/A year-over-year to $93.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $281.1 million (changed N/A YoY) and the FY2025 annual result came in at $187.7 million, changed N/A from the prior year.
  • Gross Profit climbed to $93.4 million in Q1 2026 per SLNO's latest filing, from $90.9 million in the prior quarter.
  • Across five years, Gross Profit topped out at $93.4 million in Q1 2026 and bottomed at $32.0 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn
7 Evaxion A 64.16 Bn 64.14 Bn -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn
10 Soleno Therapeutics 2.76 Bn 2.51 Bn 93.41 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 93.41 Mn
Mar 31, 2026 93.41 Mn
Dec 31, 2025 90.87 Mn
Dec 31, 2025 90.87 Mn
Sep 30, 2025 64.88 Mn
Sep 30, 2025 64.88 Mn
Jun 30, 2025 31.96 Mn
Jun 30, 2025 31.96 Mn
Jun 30, 2017 -41,000.00
Jun 30, 2017 -41,000.00
Mar 31, 2017 56,000.00
Mar 31, 2017 56,000.00
Dec 31, 2016 61,482.00
Dec 31, 2016 61,482.00
Sep 30, 2016 -70,000.00
Sep 30, 2016 -70,000.00
Jun 30, 2016 -49,000.00
Jun 30, 2016 -49,000.00
Mar 31, 2016 -14,000.00
Mar 31, 2016 -14,000.00
Dec 31, 2015 -15,211.00
Dec 31, 2015 -15,211.00
Sep 30, 2015 191,000.00
Sep 30, 2015 191,000.00
Jun 30, 2015 75,000.00
Jun 30, 2015 75,000.00
Mar 31, 2015 4,000.00
Mar 31, 2015 4,000.00